These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4387990)

  • 21. [Clinical evaluation of a new antihistaminic: HS-592].
    von Bernath Z
    Prensa Med Argent; 1971 Jul; 58(21):1071-5. PubMed ID: 4398545
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapeutic effectiveness of a new antihistaminic, derivative of benzhydryl ether (HS 592), in various allergic diseases].
    Stroescu V; Popescu IG; Dumitrescu C
    Stud Cercet Med Interna; 1969; 10(4):365-9. PubMed ID: 4391855
    [No Abstract]   [Full Text] [Related]  

  • 23. [Allergic rhinitis treated with Tavegyl].
    Ronning-Arnesen A
    Tidsskr Nor Laegeforen; 1971 Nov; 91(32):2329-31. PubMed ID: 4399793
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical experience with a new antihistaminic].
    Wolfram S
    Wien Med Wochenschr; 1967 Sep; 117(38):868-70. PubMed ID: 4385553
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical tests with a new antihistaminic (HS-592)].
    Belda W
    Hospital (Rio J); 1969 Nov; 76(5):1628-33. PubMed ID: 4392094
    [No Abstract]   [Full Text] [Related]  

  • 26. Meclastine in hay fever.
    Practitioner; 1972 Jun; 208(248):839-42. PubMed ID: 4402970
    [No Abstract]   [Full Text] [Related]  

  • 27. [Case reports in clinical treatment with a synthetic antihistaminic: HS 592].
    Giamperi M
    Folia Allergol (Roma); 1971; 18(1):69-82. PubMed ID: 4397373
    [No Abstract]   [Full Text] [Related]  

  • 28. A new antihistaminic drug (Tavegyl) in allergic diseases.
    Hajós M
    Ther Hung; 1971; 19(2):67-9. PubMed ID: 4152119
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical study of a new antihistaminic agent, Tavist].
    Gyde MC
    Vie Med Can Fr; 1972 Feb; 1(2):151-5. PubMed ID: 4404676
    [No Abstract]   [Full Text] [Related]  

  • 30. [The results of treatment of urticaria, prurigo and eczema with small doses of a new antihistaminic].
    Rudzki E; Koźmińska A; Borkowski W
    Z Haut Geschlechtskr; 1968 May; 43(9):387-90. PubMed ID: 4387024
    [No Abstract]   [Full Text] [Related]  

  • 31. H1-antihistamines in the elderly.
    Kaliner MA
    Clin Allergy Immunol; 2002; 17():465-81. PubMed ID: 12113227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [HS 592 (Tavegil) in the treatment of allergic manifestations in otorhinolaryngoiatry. Clinical contribution].
    Biscaro G
    Arch Ital Otol Rinol Laringol Patol Cervicofacc; 1969; 80(4):285-95. PubMed ID: 4394333
    [No Abstract]   [Full Text] [Related]  

  • 33. [How do we look for the right pharmaceutical care? H1 antihistamine medication].
    Teerling U
    Pharm Unserer Zeit; 2004; 33(2):124-35. PubMed ID: 15083622
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical trials of a new antihistaminic HS 592.
    Safwat FM
    Rev Laryngol Otol Rhinol (Bord); 1972; 93(11):743-6. PubMed ID: 4146016
    [No Abstract]   [Full Text] [Related]  

  • 35. [The first impressions of the therapeutic effect of mequitazine (Primalan) in allergic patients].
    Kosturkov G; Mileva Zh; Racheva R; Boĭkikeva M; Mustakov B
    Vutr Boles; 1990; 29(4):88-92. PubMed ID: 1980766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tavegyl in treatment of allergic skin diseases].
    Kibler-Nockowska M
    Wiad Lek; 1974 Apr; 27(7):645-8. PubMed ID: 4151284
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experience in the clinical use of Tavegyl in nose diseases--judgment of effectiveness by cross-over method].
    Sugiura S
    Jibiinkoka; 1971 Nov; 43(11):931-42. PubMed ID: 4401875
    [No Abstract]   [Full Text] [Related]  

  • 38. Hay fever and allergy in general practice: two antihistamine drugs compared.
    Gomez J; Gomez G
    Br J Clin Pract; 1967 Aug; 21(8):401-3. PubMed ID: 4383828
    [No Abstract]   [Full Text] [Related]  

  • 39. [Evaluation of the clinical usefulness of the antihistamine preparation HS-592 (Tavegyl-Sandoz) in treatment of allergic rhinitis and sinusitis].
    Semczuk B; Klonowski S
    Pol Tyg Lek; 1970 Feb; 25(8):303-5. PubMed ID: 4392044
    [No Abstract]   [Full Text] [Related]  

  • 40. [Results of the use of a new synthetic antihistaminic (HS 592) in ophthalmology].
    Laverone F
    Ann Ottalmol Clin Ocul; 1968 Oct; 94(10):1217-24. PubMed ID: 4389858
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.